You're really scraping the barrel here, natway!!
I can't provide any proof for what you're asking because I m unwilling. Why should I display photocopies of my own personal medical records on a public website -- get real !!
But I think I've provided enough proof as to the reasons why my protocol works. What's more I'm not asking you for any money for this protocol -- because it's already out there.
As far as I'm concerned the choice is up to you. It really doesn't concern me whether you believe in this cure or not. If you don't believe me and don't take the protocol then that is entirely up to you. I'm not responsible for your health -- you are the only person responsible for your own health and so you have every right to decide how to cure your own problems.
In other words, if you don't believe all the reasons why this protocol works, then simply don't use the protocol. I'm fine with that. And since I'm not really after anybody's money, your decsion whether to take the protocol or not makes absolutely no difference to me at all.
Some questions for you;
Have you cured your own candida problems using only a special diet ? Has this approach cured your "malnutrition problems" or do your "malnutrition problems" just keep coming back and never go away ?
And if you have cured you own candida or "malnution problems" using a diet, then would you care to share this diet with everyone here on curezone? And could you, for my benefit, also include the reasons, in detail, as to why you believe your special diet cured your "malnutrition" problems.
You're a lazy arguer, natway. I'm forcing you to give me good reasons and eviidence for your beliefs. And please don't bother to list "opinions" from doctors who are clueless about candida(I've seen that post). I would prefer real research evidence from sources like Pubmed and Medline.
Meanwhile, here's a wee bit of evidence on candida behaviour from my book in support of my own beliefs about candida problems
1. Truss CO, The Missing Diagnosis; The Missing Diagnosis: 1983.
2. Crook WG, et al, The Yeast Connection: A Medical Breakthrough; Jackson Professional Books Inc: Tennessee, 1991.
3. Crook WG, The Yeast Connection and Women’s Health; Professional Books Inc: Jackson, Tennessee, 2003.
4. Grisanti RJ, Understanding the Candida Infection. Your Medical Detective online, 2013. http://www.yourmedicaldetective.com/public/254.cfm
5. Calderone RA, et al, Virulence factors of Candida Albicans. Trends Microbiol. 2001 Jul; 9 (7): 327-35; July 2001. http://www.ncbi.nlm.nih.gov/pubmed/11435107
6. Walter Last, Overcoming Candida: A Guide to Self Healing; Austpac Productions: Moss Vale, Australia, Revised Edition, 2012.
7. Moore CW, The Candida Syndrome: Health Nemesis or Myth? Natural Life Magazine online. http://www.naturallifemagazine.com/9804/candida.htm
8. Truss CO, Metabolic Abnormalities in Patients with Chronic Candidiasis: The Acetaldehyde Hypothesis. Jour of Orthomol Psych; 13 (2); 1984. http://www.orthomolecular.org/library/jom/1984/pdf/1984-v13n02-p066.pdf
9. Weiss J, The Candida Aldehyde Detox Pathway And The Molybdenum Connection. Candidapage online, Oct 2009. http://candidapage.com/aldehyde.shtml
10. Truss OC, Tissue Injury Induced by Candida Albicans: Mental and Neurologic Manifestations. Orthomol. Psychiatry, 7 (1); pp 17-37; 1978. http://orthomolecular.org/library/jom/1978/pdf/1978-v07n01-p017.pdf
11. Trowbridge JP, Walker M, The Yeast Syndrome: How to Help Your Doctor Identify & Treat the Real Cause of Your Yeast-Related Illness; Bantam Books, New York, 1986.
12. Bakker E, Why Do Doctors Often Miss Candida Diagnosis? YeastInfection.org online, July 13, 2013. http://www.yeastinfection.org/why-do-practitioners-often-miss-the-candida-dia...
13. Evans SE, Coping with Candida Infections. Proc Am Thorac Soc; 7 (3); pp 197-203; May 2010. http://pats.atsjournals.org/content/7/3/197.full.pdf
14. Ray TL, Systemic Candidiasis, Dermatol Clin; 7(2): pp 259-68; April 1989. http://www.ncbi.nlm.nih.gov/pubmed/2670371
15. Jehn U, Managing fungal and viral infection in the immunocompromised host. Recent Results, Cancer Res; 108: pp 61-70; 1988. http://www.ncbi.nlm.nih.gov/pubmed/3051213
16. Anane S, et al, Biological diagnosis of systemic candidiasis: difficulties and future prospects. Pathol Biol (Paris); 55 (5): pp 262-72; June 2007. http://www.ncbi.nlm.nih.gov/pubmed/16698196
17.Gaby AR, Recurrent Candidiasis: One Step Forward, Still Backward. Townsend Letter for Doctors and Patients, Townsend Letter online, No 2004 v. http://www.townsendletter.com/Nov2004/gabyeditorial1104.htm
18. Pfaller MA, et al, Epidemiology of Invasive Candidiasis: A Persistent Public Health Problem. Dept of Epidemiology, University of Iowa, Clin. Microbiol. Rev; 20 (1); pp 133-163. Jan 2007
19. DiNubile MJ, et al. Invasive candidiasis in cancer patients: Observations from a randomized clinical trial. J. Infect; 50 (5); pp 443-9; Jun 2005. http://www.ncbi.nlm.nih.gov/pubmed/15907554
20. Hopfer RL, et al. Radiometric detection of yeasts in blood cultures of cancer patients. Journ. of Clin. Micro; pp 329-331; Sept 1980. http://jcm.asm.org/content/12/3/329.full.pdf
21. Degregorio MW, et al, Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Science Direct online; Cancer: 50 (12): pages 2780–2784, Dec 1982. http://onlinelibrary.wiley.com/doi/10.1002/1097-0142 1982121550:12%3C2780::AID-CNCR2820501215%3E3.0.CO;2-P/abstract
22. Novey HS, et al, Prevalence of Aspergillus and Candida Precipitins in Renal Dialysis and Transplant Patients. Informa Care online, Renal Fail; Vol. 3, No. 4, Pages 349-360; 1979. http://informahealthcare.com/doi/abs/10.3109/08860227909063952?journalCode=rnf
23. Lipsitch M, et al, Antimicrobial Use and Antimicrobial Resistance: A Population Perspective. CDC, Emerg. Infect. Dis: 84; p. 347 -354; April 2002. http://www.ncbi.nlm.nih.gov/pmc/articles
24. Kumamoto AC, Candida biofilms. Dept Mol. Biol, Tufts Uni., Boston: 5 (6); pp 608-611; Dec 2002. http://www.sciencedirect.com/science/article/pii/S1369527402003715
25. Leroy LO, et al, Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France. Critical Care Medicine online, CCM; Vol 37; Issue 5; pp 1612-1618; May 2009. http://journals.lww.com/ccmjournal/Abstract/2009/05000/Epidemiology,_manageme...
26. Krčméry V, et al, Documented Fungal Infections after Prophylaxis or Therapy with Wide Spectrum Antibiotics: Relationship Between Certain Fungal Pathogens and Particular Antimicrobials. Journal of Chemotherapy (Florence, Italy): 115: pp 385-390; 1999. http://europepmc.org/abstract/MED/10632385
27. Picazo JJ, et al, Candidemia in the critically ill patient. Int J Antimicrob Agents. 32 Suppl 2: pp 83-5; Nov 2008. http://www.ncbi.nlm.nih.gov/pubmed/19013345
28. Delisle MS, et al, The Clinical Signiﬁcance of Candida Colonization of Respiratory Tract Secretions in Critically Ill Patients. Can Respir Jour: 183; May-June 2011. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328877/
29. Dorko E, et al, Fungal diseases of the respiratory tract. Folia Microbiologica Jour; Volume 47, Issue 3, pp 302-304; June 2002. http://www.springerlink.com/content/a59677t885011304/
30. Knutsen AP, et al, Fungi and allergic lower respiratory tract diseases. Jour of Allergy and Clinical Immunology; Volume 129, Issue 2, pp 280-291, Feb 2012. http://www.jacionline.org/article/S0091-6749 1102939-3/abstract
31. Santelmann H, et al, Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome, Euro Journal of Gastro & Hepatol. Dis; 171: pp 21-6; Jan 2005. http://www.ncbi.nlm.nih.gov/pubmed/15647635
32. Cater, RE, Chronic candidiasis as a possible etiological factor in the chronic fatigue syndrome. Medical Hypotheses; 446: pp 507-15; June 1995. http://www.ncbi.nlm.nih.gov/pubmed/7476598
33. Hazen KC, Chronic Urinary Tract Infection Due to Candida utilis. Jour Clinical Microbiol; 373; pp 824 -827; March 1999. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC84571/
34. Seelig MS, Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriol Rev; 302: pp 442-459; June 1966. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC441005/
35. Sendid B, et al, Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease. Med Sci (Paris); 255: pp 473-81; 2009 May. http://www.ncbi.nlm.nih.gov/pubmed/19480828
36. Garst J, Yeast organisms and Prostatitis. Prostatitis Foundation online, 2002. http://www.prostatitis.org/yeastessay.html
37. Kerridge D, Fungal Dimorphism: A Sideways Look. Dimorphic Fungi in Biology and Medicine; pp 3-10; 1993. http://link.springer.com/chapter/10.1007/978-1-4615-2834-0_1
38. Hartmann J, Pleomorphism as a Therapeutic Principle for Candida Mycoses. SANUM-Post magazine; 18/1992. http://www.semmelweis.de/pdf/pdf.php?name=18_hartmann_albicansan_gbr&ext=pdf
39. Molero G, et al, Candida albicans: genetics, dimorphism and pathogenicity. International Microbiol; 1: pp 95-106; 1998. http://www.im.microbios.org/02june98/04%20Molero.pdf
40. Mitchell AP, Dimorphism and virulence in Candida albicans. Curr Opin Microbiol: 16:687-92; Dec 1998. http://www.ncbi.nlm.nih.gov/pubmed/10066539
41. Olmtead SF, et al, Life on the edge: the clinical implications of gastrointestinal biofilm. Townsend Letter online; Oct 2009. http://www.thefreelibrary.com/Life+on+the+edge:+the+clinical+implications+of+gas%20trointestinal+ .-a0211561662
42. Chandra J, et al, Biofilm Formation by the Fungal Pathogen Candida albicans: Development, Architecture, and Drug Resistance. J Bacteriol.; 18318: pp 5385-94; Sep 2001. http://www.ncbi.nlm.nih.gov/pubmed/11514524
43. Ramage G, et al, Fungal biofilm resistance. Int J Microbiol; 528521; Feb 2012. http://www.ncbi.nlm.nih.gov/pubmed/22518145
44. Ramage G, et al, Candida Biofilms: an Update. Eukarotic Cell; 44; pp 633 -638; April 2005. http://ec.asm.org/content/4/4/633.full
45. Douglas L J, Candida biofilms and their role in infection. Trends Microbiol; 111: pp 30-6; Jan 2003. http://www.sciencedirect.com/science/article/pii/S0966842X02000021Glasgow
46. Didilescu A, Biofilms. Pneumologia; 531: pp 26-30; Jan-Mar 2004. http://www.ncbi.nlm.nih.gov/pubmed/18210718
47. Hawser SP, et al, Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemotherapy; Vol. 39 no. 9; pp 2128-2131; Sep 1995. http://aac.asm.org/content/39/9/2128.short
48. Baillie GS et al, Role of dimorphism in the development of Candida albicans biofilms. Journal of Medical Microbiology online. JMM; vol. 48 no. 7; pp 671-679; July 1999. http://jmm.sgmjournals.org/content/48/7/671.short
49. Sardi JC, et al, Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options, J Med Microbiol: 62Pt 1: pp 10-24. Jan 2013. http://www.ncbi.nlm.nih.gov/pubmed/23180477
50. Hogan DA, Talking to Themselves: Autoregulation and Quorum Sensing in Fungi. Eukaryot Cell; 54: pp 613-9; Apr 2006. http://www.ncbi.nlm.nih.gov/pubmed/16607008
51. Nguyen D, et al, Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria. Science: Vol; 334; no. 6058; pp 982-986; Nov 2011. http://www.sciencemag.org/content/334/6058/982
52. Ash C, Arrest and Tolerate. Sci. Signal., Vol. 4, Issue 200, pp. 328; Nov 2011. http://stke.sciencemag.org/cgi/content/abstract/4/200/ec328
53. Adam B, et al, Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol; 51(4); pp 344-349; April 2002. http://jmm.sgmjournals.org/content/51/4/344.short
54. Thein ZM, et al, Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses; 52 (6); pp 467-475, Nov 2009. http://onlinelibrary.wiley.com/doi/10.1111/j.1439-0507.2009.01719.x/abstract
Is this enough evidence ? Or would you like some more ?
Add To Favorites!